On September 21, at the 36Kr Waves.2023 Industrial Future Conference, CEC Capital was honored with the exclusive title of "2023 China Best Industrial Empowerment Investment Bank in Healthcare." It was the only investment banking institution recognized in the healthcare sector.

In recent years, CEC Capital has consistently received accolades in the healthcare domain. In 2022, it secured the top position in Qimingpian's "2022 China Annual Healthcare Financial Advisor Ranking," and from 2019 to 2023, it has been consecutively recognized as the "Annual Healthcare Financial Advisor Institution" by Vbdata for five years.

This unique accolade from 36Kr underscores CEC Capital's leading market position, extensive influence, and robust service capabilities in the Chinese healthcare industry.

As an investment bank that comprehensively covers the health, technology, and consumer markets, CEC Capital has also received numerous accolades for overall excellence. In 2021, it was honored with China Venture LIST's "Top 3 Best New-Type Investment Banks in China for 2021" and 36Kr's "2021 Most Influential New-Type Investment Bank" award. In 2020, it received 36Kr's "Top 3 Most Influential New-Type Investment Banks in China for 2020." In 2019, CEC Capital was recognized as the "Top 3 Best New-Type Investment Banks in China for 2019" by China Venture LIST and awarded "Best FA Institution in China for 2019" by China FoF Alliance, among other honors.